AzTrials
AzTrials

Carotid Artery, ExternalPhase 3IRM-de-FLUXNCT02829190

Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries

A Phase 3 study testing Magnetic Resonance Imaging (MRI), in people with Carotid Artery, External, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The phase-contrast MRI offers the advantage to combine precisely vascular flow measurements data with morphological images. Even if the anatomy of the external carotid artery is well known, data obtained through Phase contrast MRI could permit to progress in several fields of cranio-maxillofacial surgery as for… Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Carotid Artery, External
What is being tested?
Magnetic Resonance Imaging (MRI),
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteFrance
Study dates
6 Jan 2014to Dec 2027
Phase
Phase 3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • group 1 : healthy volunteer
  • group 2 : X-Ray treatment antecedent (at least 50 grays and older than one year)
  • group 3 : antecedent of embolization of branches of external carotid artery
  • group 4 : antecedent of muscular free flap surgery (older than one month)
  • free and informed consent

Who cannot join

  • group 1 : facial pathology, antecedent of facial injury, antecedent of X-Ray treatment in head and neck localisation, antecedent of head and neck cancer
  • group 2 : antecedent of surgery for head and neck cancer or for vascular disease
  • group 3 : antecedent of surgery for head and neck cancer or for vascular disease ; antecedent of X-Ray treatment.
  • group 4 : antecedent of surgery for head and neck cancer or for vascular disease ; antecedent of X-Ray treatment or embolization
  • patient with guardianship or trusteeship
  • MRI cons-indications
  • pregnancy and lactation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Departement of Maxillo-Facial Surgery, Amiens University Hospital

    Amiens, Picardie, 80054

    Bernard DEVAUCHELLE, MD, phD, 0033 3 22 08 90 50, devauchelle.bernard@chu-amiens.fr

    Stéphanie DAKPE, MD

    Recruiting

Other trials in France

About this study

Official title: Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries in Normal and Pathological Cases

The phase-contrast MRI offers the advantage to combine precisely vascular flow measurements data with morphological images.

Even if the anatomy of the external carotid artery is well known, data obtained through Phase contrast MRI could permit to progress in several fields of cranio-maxillofacial surgery as for example arteriovenous malformations,radionecrosis, head and neck micro-reconstructive surgery.

The aim of this study is to establish and develop Phase-contrast MRI sequences for vascular flow characterization branches of the external carotid artery in healthy patients and in pathological cases.

Being tested
Magnetic Resonance Imaging (MRI),
Keywords
External carotid artery, Facial artery, Lingual artery, Superior thyroid artery, Internal maxillary artery, Phase-contrast MRI, Rate of flow, Superficial temporal artery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic Resonance Imaging (MRI),Device

    Magnetic Resonance Imaging (MRI) of flow using phase contrast (PC) methods

Study groups in NCT02829190
Study groupRoleWhat they receive
Healthy volunteersExperimentalMagnetic Resonance Imaging (MRI)
Receives: Device: Magnetic Resonance Imaging (MRI),
Patients treated by radiotherapyExperimentalMagnetic Resonance Imaging (MRI)
Receives: Device: Magnetic Resonance Imaging (MRI),
Patients treated by embolizationExperimentalMagnetic Resonance Imaging (MRI)
Patient operated on with free flapExperimentalMagnetic Resonance Imaging (MRI)
Receives: Device: Magnetic Resonance Imaging (MRI),

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measurability of flow 1

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the maximum speed

    Measured: 1 hour

  2. measurability of flow 2

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the minimum speed

    Measured: 1 hour

  3. measurability of flow 3

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the average speed

    Measured: 1 hour

  4. measurability of flow 4

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the maximum flow rates

    Measured: 1 hour

  5. measurability of flow 5

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the minimal flow rates

    Measured: 1 hour

  6. measurability of flow 6

    flow data in the branches of external carotid artery in every 4 groups, characterized by measuring the medium flow rates

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2016 (estimated)
  2. Study start6 Jan 2014
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02829190
Sponsor's protocol ID
PI2013_843_0006
Other IDs
2013-A00319-36
Acronym
IRM-de-FLUX
Status last verified
May 2026
First submitted
1 Dec 2014
Last updated
13 May 2026
Results posted
No
Data monitoring committee
No

Publications

  • Baledent O, Fin L, Khuoy L, Ambarki K, Gauvin AC, Gondry-Jouet C, Meyer ME. Brain hydrodynamics study by phase-contrast magnetic resonance imaging and transcranial color doppler. J Magn Reson Imaging. 2006 Nov;24(5):995-1004. doi: 10.1002/jmri.20722.

    PubMed 17024656
  • Cadenat H, Barthelemy R, Combelles R, Fabie M, Maneaud M. [Importance of mandibular vascularization in maxillofacial surgery]. Rev Stomatol Chir Maxillofac. 1972 Jan-Feb;73(1):60-5. No abstract available. French.

    PubMed 4504634
  • Castelli WA, Nasjleti CE, Diaz-Perez R. Interruption of the arterial inferior alveolar flow and its effects on mandibular collateral circulation and dental tissues. J Dent Res. 1975 Jul-Aug;54(4):708-15. doi: 10.1177/00220345750540040301.

    PubMed 808564
  • Combelles R, Manelfe C, Hugot B, Pasturel J, Barthelemy R, Fabie M, Cadenat H. [Selective catherization of the external carotid in stomatology]. Rev Odontostomatol Midi Fr. 1974;32(1):19-37. No abstract available. French.

    PubMed 4438882
  • Dakpé, S., 2007. Allotransplantation faciale composite: reflexion à propos de l'intégration de trois greffons expérimentaux.Université Paris XI.

  • Decorato I, Kharboutly Z, Vassallo T, Penrose J, Legallais C, Salsac AV. Numerical simulation of the fluid structure interactions in a compliant patient-specific arteriovenous fistula. Int J Numer Method Biomed Eng. 2014 Feb;30(2):143-59. doi: 10.1002/cnm.2595. Epub 2013 Nov 5.

    PubMed 24493402
  • d'Hauthuille C, Testelin S, Moure C, Gbaguidi C, Devauchelle B. [Mandibular osteoradionecrosis. Part II: efficiency of revascularization surgery]. Rev Stomatol Chir Maxillofac. 2008 Nov;109(5):296-300. doi: 10.1016/j.stomax.2007.12.009. Epub 2008 Jun 4. French.

    PubMed 18534648
  • Frydrychowicz A, Francois CJ, Turski PA. Four-dimensional phase contrast magnetic resonance angiography: potential clinical applications. Eur J Radiol. 2011 Oct;80(1):24-35. doi: 10.1016/j.ejrad.2011.01.094. Epub 2011 Feb 17.

    PubMed 21333479
  • Gauvrit J, Trystram D, Oppenheim C, Leclerc X. [Advanced vascular imaging techniques of supra-aortic, encephalic and medullary vessels]. J Radiol. 2007 Mar;88(3 Pt 2):472-82. doi: 10.1016/s0221-0363(07)89847-7. French.

    PubMed 17457258
  • Herment A, Lefort M, Kachenoura N, De Cesare A, Taviani V, Graves MJ, Pellot-Barakat C, Frouin F, Mousseaux E. Automated estimation of aortic strain from steady-state free-precession and phase contrast MR images. Magn Reson Med. 2011 Apr;65(4):986-93. doi: 10.1002/mrm.22678. Epub 2010 Nov 3.

    PubMed 21413062
  • Houseman ND, Taylor GI, Pan WR. The angiosomes of the head and neck: anatomic study and clinical applications. Plast Reconstr Surg. 2000 Jun;105(7):2287-313. doi: 10.1097/00006534-200006000-00001.

    PubMed 10845282
  • Maurits NM, Loots GE, Veldman AE. The influence of vessel wall elasticity and peripheral resistance on the carotid artery flow wave form: a CFD model compared to in vivo ultrasound measurements. J Biomech. 2007;40(2):427-36. doi: 10.1016/j.jbiomech.2005.12.008. Epub 2006 Feb 7.

    PubMed 16464454
  • Morita S, Suzuki K, Masukawa A, Kojima S, Hirata M, Ueno E. Identification of efferent flow in the superior vena cava and azygos vein confluence using cine phase-contrast MRI: speculation of the role of the azygos arch valves. Magn Reson Imaging. 2010 Nov;28(9):1306-10. doi: 10.1016/j.mri.2010.06.005. Epub 2010 Aug 4.

    PubMed 20685054
  • Mouton Paradot G, Baledent O, Sallioux G, Lehmann P, Gondry-Jouet C, Le Gars D. [Contribution of phase-contrast MRI to the management of patients with normal pressure hydrocephalus: Can it predict response to shunting?]. Neurochirurgie. 2010 Feb;56(1):50-4. doi: 10.1016/j.neuchi.2009.12.007. Epub 2010 Jan 25. French.

    PubMed 20097391
  • Nayler GL, Firmin DN, Longmore DB. Blood flow imaging by cine magnetic resonance. J Comput Assist Tomogr. 1986 Sep-Oct;10(5):715-22. doi: 10.1097/00004728-198609000-00001.

    PubMed 3528245

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Magnetic Resonance Imaging (MRI), in people with Carotid Artery, External, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stéphanie DAKPE, MD (03 22 08 90 50 ext. 033, dakpe.stephanie@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measurability of flow 1 (time frame: 1 hour). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02829190, which also lists 21 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in